340 likes | 481 Views
LUNG TRANSPLANTATION. Pediatric Recipients. ISHLT. 2005. J Heart Lung Transplant 2005;24: 945-982. AGE DISTRIBUTION OF PEDIATRIC LUNG RECIPIENTS (Transplants: January 1986 - June 2004). ISHLT. 2005. J Heart Lung Transplant 2005;24: 945-982.
E N D
LUNG TRANSPLANTATION Pediatric Recipients ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
AGE DISTRIBUTION OF PEDIATRIC LUNG RECIPIENTS (Transplants: January 1986 - June 2004) ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
AGE DISTRIBUTION OF PEDIATRIC LUNG RECIPIENTS (Transplants: January 1996 - June 2004) ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
AGE DISTRIBUTION BY DONOR TYPE FOR PEDIATRIC LUNG RECIPIENTS(Transplants: January 1986 - June 2004) ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
AGE DISTRIBUTION BY DONOR TYPE FOR PEDIATRIC LUNG RECIPIENTS (Transplants: January 1996 - June 2004) ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
AGE DISTRIBUTION FOR DONORS OFPEDIATRIC LUNG RECIPIENTS(Transplants: January 1986 - June 2004) ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
AGE DISTRIBUTION FOR DONORS OFPEDIATRIC LUNG RECIPIENTS(Transplants: January 1996 - June 2004) ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
84 84 84 AGE DISTRIBUTION OF PEDIATRIC LUNG RECIPIENTSBy Year of Transplant 72 67 66 65 63 57 51 47 45 43 Number of Transplants 20 6 3 4 1 ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
NUMBER OF CENTERS REPORTING PEDIATRIC LUNG TRANSPLANTS ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
PEDIATRIC LUNG TRANSPLANTATION: Indications(Transplants: January 1991 - June 2004) ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
DIAGNOSIS IN PEDIATRIC LUNG RECIPIENTSAge: 11-17 Years ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
PEDIATRIC LUNG TRANSPLANTATIONKaplan-Meier Survival by Procedure Type (Transplants: January 1990 - June 2003) P = 0.0003 ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
PEDIATRIC LUNG TRANSPLANTATIONKaplan-Meier Survival for Congenital Diagnosis(Transplants: January 1990 – June 2003) ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
PEDIATRIC LUNG TRANSPLANTATIONKaplan-Meier Survival by Procedure TypeDiagnosis: Primary Pulmonary Hypertension (Transplants: January 1990 - June 2003) P = 0.003 ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
PEDIATRIC LUNG TRANSPLANTATIONKaplan-Meier Survival by Age Group (Transplants: January 1990 - June 2003) ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
PEDIATRIC LUNG TRANSPLANTATIONConditional Kaplan-Meier Survival by Age Group(Transplants: January 1990 - June 2003) HALF-LIFE <1 Year: 7.1 Years 1-10 Years: 10.5 Years 11-17 Years: 6.1 Years ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
PEDIATRIC LUNG TRANSPLANTATION Kaplan-Meier Survival by Era (Transplants: January 1988 - June 2003) ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
PEDIATRIC LUNG TRANSPLANTATIONKaplan-Meier Survival by Donor Type for Age 11-17 years(Transplants: January 1990 - June 2003) HALF-LIFE Deceased: 3.7 Years Living: 3.8 Years ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
PEDIATRIC LUNG RECIPIENTS Functional Status of Surviving Recipients(Follow-ups: April 1994-June 2004) ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
PEDIATRIC LUNG RECIPIENTS Rehospitalization Post-transplant of Surviving Recipients(Follow-ups: April 1994 - June 2004) ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
PEDIATRIC LUNG RECIPIENTS Induction ImmunosuppressionFor follow-ups between January 2001 and June 2004 ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
PEDIATRIC LUNG RECIPIENTSInduction Immunosuppression (Follow-ups: January 2001 - June 2004) ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
PEDIATRIC LUNG RECIPIENTSMaintenance Immunosuppression at Time of Follow-up(Follow-ups: January 2001 and June 2004) NOTE: Different patients are analyzed in Year 1 and Year 5 ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
PEDIATRIC LUNG TRANSPLANTATIONKaplan-Meier Survival Stratified by Induction Use(Transplants: January 2001 - June 2004) ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
PEDIATRIC LUNG RECIPIENTSMaintenance Immunosuppression at Time of Follow-up(Follow-ups: January 2001 and June 2004) 1 Year Follow-up (N = 118) 5 Year Follow-up (N = 66) NOTE: Different patients are analyzed in Year 1 and Year 5 ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
PEDIATRIC LUNG RECIPIENTSMaintenance Immunosuppression Drug Combinations at Time of Follow-up Report (Follow-ups: January 2001 and June 2004) NOTE: Different patients are analyzed in Year 1 and Year 5 ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
POST-LUNG TRANSPLANT MORBIDITY FOR PEDIATRICSCumulative Prevalence in Survivors within 1 Year Post-Transplant (Follow-ups: April 1994 - June 2004) ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
POST-LUNG TRANSPLANT MORBIDITY FOR PEDIATRICSCumulative Prevalence in Survivors within 5 Years Post-Transplant (Follow-ups: April 1994 - June 2004) ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
Freedom from Bronchiolitis ObliteransFor Pediatric Lung Recipients(Follow-ups: April 1994 - June 2004) ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
Freedom from Severe Renal Dysfunction*For Pediatric Lung Recipients(Follow-ups: April 1994 - June 2004) * Severe renal dysfunction = Creatinine > 2.5 mg/dl, dialysis or renal transplant ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
FREEDOM FROM BRONCHIOLITIS OBLITERANSFor Pediatric Lung Recipients by Induction Use(Transplants: April 1994 - June 2004) ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
MALIGNANCY POST-LUNG TRANSPLANTATION FOR PEDIATRICSCumulative Incidence for Survivors(Follow-ups: April 1994 - June 2004) ”Other” includes Liver and primitive neuroectodermal tumor. ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
Freedom from MalignancyFor Pediatric Lung Recipients(Follow-ups: April 1994 - June 2004) ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
PEDIATRIC LUNG TRANSPLANT RECIPIENTS: Cause Of Death(Deaths: January 1992- June 2004) ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982